XRTX

XORTX Therapeutics Inc. XRTX

XRTX
XORTX Therapeutics Inc. GLMD
Galmed Pharmaceuticals Ltd. CERO
CERo Therapeutics Holdings, Inc. ARTL
Artelo Biosciences, Inc. OCEA
Ocean Biomedical, Inc. CMMB
Chemomab Therapeutics Ltd. BIVI
BioVie Inc. MLEC
Moolec Science S.A. LIMN
Liminatus Pharma, Inc. Class A Common Stock PTIX
Protagenic Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode XRTX GLMD CERO ARTL OCEA CMMB BIVI MLEC LIMN PTIX
6M 2.06 % 7.35 % -78.22 % -27.84 % -86.11 % -27.16 % -75.28 % -90.42 % -75.85 % -11.11 %
YTD -24.80 % -56.02 % -97.87 % -35.78 % -98.99 % -60.33 % -91.01 % -91.71 % -75.85 % -55.98 %
1Y -59.46 % -59.89 % -98.59 % -45.74 % -99.39 % -32.94 % -82.65 % -92.61 % -75.85 % -59.13 %
3Y -89.14 % -97.77 % -99.99 % -78.46 % -99.94 % -58.37 % -99.28 % -93.27 % -75.85 % -90.48 %
5Y -96.89 % -99.75 % -99.99 % -92.55 % -99.94 % -95.41 % -99.80 % -93.07 % -75.85 % -97.47 %
10Y -96.89 % -99.92 % -99.99 % -99.00 % -99.94 % -99.51 % -98.69 % -93.07 % -75.85 % -97.47 %
From the beginning -96.89 % -99.94 % -99.99 % -99.00 % -99.94 % -99.51 % -99.48 % -93.07 % -75.85 % -97.47 %

Dividend

XORTX Therapeutics Inc.

Protagenic Therapeutics, Inc.